De Felipe M C, De Ceballos M L, Gil C, Fuentes J A
Eur J Pharmacol. 1985 May 28;112(1):119-22. doi: 10.1016/0014-2999(85)90247-x.
Chronic (21 consecutive days) and not acute administration of typical (clomipramine, desipramine, amitriptyline) or atypical (iprindole, nomifensin) antidepressant drugs was found to provoke a selective increase in [Met5]enkephalin-like immunoreactivity ([Met5]ELI) in striatum and nucleus accumbens of rat brain. In parallel experiments, following chronic treatment with clomipramine, iprindole and nomifensin striatal [Leu5]enkephalin-like immunoreactivity ([Leu5]ELI) was also significantly enhanced. No variations in enzymatic activity of either enkephalinase or aminopeptidase were detected when assayed in several brain parts of animals chronically treated with antidepressants. Elevation of ELI in discrete regions of the brain might play a part in the mechanism of action of these centrally acting agents.
研究发现,对大鼠脑进行典型(氯米帕明、去甲丙咪嗪、阿米替林)或非典型(伊普吲哚、诺米芬辛)抗抑郁药物的慢性(连续21天)而非急性给药,会引起纹状体和伏隔核中[Met5]脑啡肽样免疫反应性([Met5]ELI)选择性增加。在平行实验中,氯米帕明、伊普吲哚和诺米芬辛慢性治疗后,纹状体中[Leu5]脑啡肽样免疫反应性([Leu5]ELI)也显著增强。在用抗抑郁药慢性治疗的动物的几个脑区进行检测时,未发现脑啡肽酶或氨肽酶的酶活性有变化。脑内离散区域的ELI升高可能在这些中枢作用药物的作用机制中起作用。